A

Affinity Asset Advisors

6 employees

Affinity Asset Advisors is a healthcare-focused hedge fund with public and private investments

Investor insights

Sectors invested in

Biotechnology3

Therapeutics3

Medical2

Health Care2

structure-based drug design1

diagnostics1

start-up1

therapeutics1

biomarkers1

cancer1

drug development1

IRAK inhibitors1

FLT3 inhibitors1

oncology1

Funding rounds participated in

$53M sweet spot round size

Most of their 6 investments are in rounds between $15M and $80M

Investor type

Hedge Fund

Basic info

Industry

financial services

Sectors

Hedge Funds

Financial Services

Health Care

Date founded

2018

Investments made

C

Ceptur Therapeutics raised $75M on January 19, 2022

Investors: Perceptive Advisors, venBio Partners, Qiming Venture Partners, LifeSci Venture Partners, Bristol-Myers Squibb, UK and Affinity Asset Advisors

U

Undisclosed raised $30M on September 3, 2021

Investors: Innogest Capital, Ikarian Capital LLC, Longview Ventures, RTW Investments, LP, Altium Capital, Sio Capital Management LLC, Surveyor Capital, Acorn Bioventures and Affinity Asset Advisors

K

Kurome Therapeutics, Inc. raised $15M on June 10, 2021

Investors: Queen City Angels, Medicxi, CincyTech USA and Affinity Asset Advisors

T

Tesseract Health raised $80M on April 20, 2021

Investors: Foresite Capital and Affinity Asset Advisors

U

Undisclosed raised $90M on February 10, 2021

Investors: COLLE CAPITAL, GV, Zepp Health, Nextrans Vietnam, Altium Capital and Affinity Asset Advisors

C

Ceptur Therapeutics raised $6.2M on August 13, 2020

Investors: Affinity Asset Advisors